LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.73 0.75

Resumen

Variación precio

24h

Actual

Mínimo

18.25

Máximo

18.78

Métricas clave

By Trading Economics

Ingresos

67M

-681K

Ventas

-2.9M

17M

P/B

Media del Sector

48.528

76.798

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+10.45% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.37%

Próximas Ganancias

8 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

47M

391M

Apertura anterior

17.98

Cierre anterior

18.73

Noticias sobre sentimiento de mercado

By Acuity

21%

79%

36 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 dic 2025, 17:29 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dic 2025, 16:47 UTC

Principales Movimientos del Mercado

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dic 2025, 16:10 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

19 dic 2025, 22:33 UTC

Ganancias

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dic 2025, 22:19 UTC

Ganancias

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dic 2025, 21:48 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 21:44 UTC

Ganancias

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 21:38 UTC

Ganancias

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dic 2025, 21:00 UTC

Charlas de Mercado

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dic 2025, 20:23 UTC

Charlas de Mercado

Oil Futures End Down Week on Up Note -- Market Talk

19 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dic 2025, 18:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dic 2025, 18:00 UTC

Charlas de Mercado
Ganancias

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dic 2025, 17:41 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 17:24 UTC

Charlas de Mercado
Ganancias

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 dic 2025, 16:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dic 2025, 16:20 UTC

Adquisiciones, fusiones, absorciones

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dic 2025, 16:19 UTC

Adquisiciones, fusiones, absorciones

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dic 2025, 16:18 UTC

Adquisiciones, fusiones, absorciones

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dic 2025, 16:16 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 dic 2025, 16:16 UTC

Charlas de Mercado

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dic 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 16:04 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 15:37 UTC

Charlas de Mercado

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

19 dic 2025, 15:21 UTC

Charlas de Mercado

West-Coast Liquor Store Strike Weighed on Canada Retail Data -- Market Talk

19 dic 2025, 15:09 UTC

Charlas de Mercado

Gold Flat But Set for Weekly Gains -- Market Talk

19 dic 2025, 15:09 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

19 dic 2025, 15:09 UTC

Ganancias

FedEx Earnings Were Strong. The Stock Is Down. -- Barrons.com

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

10.45% repunte

Estimación a 12 Meses

Media 20.5 USD  10.45%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

36 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat